A man with muscular dystrophy who was first in line to receive an experimental
CRISPR therapy tailor made to treat the cause of his rare form of the disease
has died.
The first recipient of the Sharon Begley-STAT Science Reporting Fellowship is Isabella Cueto, a Cuban American journalist who has worked as a reporter in Florida, South Carolina, and California.
While it remains fairly unusual for hospital chiefs across the country to work as directors for publicly traded companies, the practice is now routine in Boston.
Research on Covid-19 dominates the bracket for this year’s #STATMadness, our annual competition in which readers choose the most important biomedical advance or discovery to emerge from U.S. labs in the past year.
When STAT began its legal fight to unseal the OxyContin files in 2016, most people didn’t understand Purdue’s and the Sacklers’ role in the opioid crisis.
It was just the occasional wiggle, but it told doctors the prosthetic foot had seamlessly become part of Jim’s body. STAT has been following this groundbreaking experiment for 15 months. Here’s what we saw.
Laura Deming went to MIT at age 14 and launched a venture capital fund that invests in anti-aging companies at 17. The fund’s mission, she said, “is that everyone in the world can live as long as they want.”